Next Generation Longevity 2026
Where leaders in precision medicine, biotechnology, regenerative therapeutics, AI, government, and food systems explore what a society can achieve when it fully commits to extending healthy years of life. Join us where the future of medicine convenes.
Curated by Experts, Designed for Impact
A small, world-class faculty with deep expertise will moderate, guide, and connect the dots across sessions.
What You Will Leave With
We design for outcomes, not applause. Every attendee receives:
Personal Action Blueprint
A one-page, prioritized playbook and three curated introductions with context, plus 30/60-day follow-ups from our Outcomes Desk.
View sample blueprint →Prototype Packet (from workshops)
For builders: an agent map, data schema, or protocol outline directly from our AI and technology workshops—ready to ship the following week.
View sample prototype →The World's Living Laboratory for Longevity
Japan is the world's most rapidly aging nation, offering a preview of the demographic and healthcare challenges all societies will face. At the same time, it holds some of the deepest cultural roots of longevity.
Center for Frontier Medicine in Osaka
Nakanoshima Qross · 未来医療国際拠点
Program
Every session is crafted with intention—designed to deliver actionable insights and concrete strategies.
Immersed in Japanese Culture
Experience the traditions that have shaped the world's longest-living population.
Matcha & Connection
Begin each day grounded in Japanese tea culture
Ikigai
The science of purpose and living well
Tea Ceremony
Mindfulness through ritual and presence
Culinary Osaka
Japan's kitchen — where food is medicine and tradition
Nakanoshima Qross
中之島クロス
Japan's government-designated medical innovation hub, established by the Future Medicine Promotion Organization with 21 private enterprises and Osaka Prefecture.
Where regenerative medicine research, clinical practice, and global knowledge exchange converge. Led by pioneering professors with deep connections to Osaka University's regenerative medicine programs.
We Build This Together
Our partners make Next Generation Longevity 2026 possible. They are co-creators in a global forum where ideas evolve into pilots, partnerships, and cross-border collaborations grounded in real-world implementation.
Conference Faculty
World-class experts guiding conversations at the intersection of longevity medicine, technology, and global health systems.
Anant Vinjamoori, MD, MBA
Harvard-trained physician and operator across Modern Age and Virta; advisor to leaders at the edge of longevity and AI. Dr. Vinjamoori brings deep expertise in scaling healthspan companies and implementing AI-driven care models.
Deepti Agarwal, MD, MBA
Triple board-certified physician specializing in precision and integrative care with a focus on prehabilitation. Dr. Agarwal champions cross-cultural approaches to longevity, bringing together Eastern and Western medicine paradigms.
Naoko Kita
Founder reshaping women's health literacy in Japan with background at J&J and Medtronic. Naoko bridges Japanese longevity traditions with modern medical technology, offering unique insights into the world's longest-living population.
Travel & Accommodations
Osaka is Japan's culinary capital and gateway to Kyoto, Nara, and the cultural heart of the country.
Getting There
Kansai International Airport (KIX) — direct flights from major US, European, and Asian cities. 50 minutes to central Osaka by express train.
Venue Location
Nakanoshima Qross on Nakanoshima Island — a short walk from major hotels, surrounded by waterfront dining and cultural attractions.
Recommended Hotels
Group rates at premium hotels near the venue including Conrad Osaka, InterContinental, and Royal Hotel.
Frequently Asked Questions
Apply to Attend
Next Generation Longevity 2026 is a curated gathering of leaders shaping the future of healthspan medicine. We review each application to ensure a high-quality experience for all attendees.
Who Should Apply
- Clinicians practicing longevity, precision, or integrative medicine
- Founders building in healthspan, biotech, or AI-health
- Investors focused on longevity and life sciences
- Corporate executives exploring preventive health strategies
- Scientists translating research into clinical practice
Applications are reviewed on a rolling basis. Qualified applicants receive an invitation within 5-7 business days.